Area of Interest under PHO ISO: ASCENT-IBO

See attached Special Notice ARPA-H-SN-26-158: Accelerating Safe Clinical Evaluation of Novel Treatments: Ibogaine for Better outcomes in OUD (ASCENT-IBO) This Special Notice builds upon ARPA-H-SN-26-156 and includes details related to a Proposers’ Day event.

• NAICS541715
• PSCAN13

• PHO ISO (ARPA-H-SOL-24-106)

  Not yet available
• ARPA-H-SN-26-156: Implementation of Executive Order 14401 Accelerating Medical Treatments for Serious Mental Illness

  Not yet available
• Submit a Question to the PHO Team

  Not yet available
• SN_26_158_ASCENT_IBO.pdf

  .pdf130 KB
  Download

• SEE DESCRIPTION SECTION
  do_not_use_this_email_address@arpa-h.gov